Tri-GalNAc-DBCO 可以与脱唾液酸糖蛋白受体 (ASGPR) 结合以驱动蛋白质下调,靶向蛋白质降解,其中 GalNAc 是一种肝细胞特异性 ASGPR 的高亲和力配体。
生物活性 | Tri-GalNAc-DBCO can bind to the desialic acidglycoproteinreceptor (ASGPR) to drive protein downregulation and target protein degradation, where GalNAc is a high-affinity ligand for hepatocyte-specific ASGPR[1]. |
分子量 | |
Formula | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |